Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

27 ways to meet PTSD: Using the PTSD-checklist for DSM-5 to examine PTSD core criteria.

Franklin CL, Raines AM, Cuccurullo LJ, Chambliss JL, Maieritsch KP, Tompkins AM, Walton JL.

Psychiatry Res. 2018 Mar;261:504-507. doi: 10.1016/j.psychres.2018.01.021. Epub 2018 Jan 11.

PMID:
29395872
2.

Improving outcomes in adults with diabetes through an interprofessional collaborative practice program.

Nagelkerk J, Thompson ME, Bouthillier M, Tompkins A, Baer LJ, Trytko J, Booth A, Stevens A, Groeneveld K.

J Interprof Care. 2018 Jan;32(1):4-13. doi: 10.1080/13561820.2017.1372395. Epub 2017 Nov 7.

PMID:
29111835
3.

The Heart of the Core.

Tompkins A.

Midwifery Today Int Midwife. 2016 Summer;(118):14-5. No abstract available.

PMID:
27464395
4.

Health, environmental change and adaptive capacity; mapping, examining and anticipating future risks of water-related vector-borne diseases in eastern Africa.

Taylor D, Kienberger S, Malone JB, Tompkins AM.

Geospat Health. 2016 Feb 18;11(1 Suppl):464. doi: 10.4081/gh.2016.464. No abstract available.

5.
6.

To what extent does climate explain variations in reported malaria cases in early 20th century Uganda?

Tompkins AM, Larsen L, McCreesh N, Taylor D.

Geospat Health. 2016 Mar 31;11(1 Suppl):407. doi: 10.4081/gh.2016.407.

7.

Projecting malaria hazard from climate change in eastern Africa using large ensembles to estimate uncertainty.

Leedale J, Tompkins AM, Caminade C, Jones AE, Nikulin G, Morse AP.

Geospat Health. 2016 Mar 31;11(1 Suppl):393. doi: 10.4081/gh.2016.393.

8.

Mosquito breeding site water temperature observations and simulations towards improved vector-borne disease models for Africa.

Asare EO, Tompkins AM, Amekudzi LK, Ermert V, Redl R.

Geospat Health. 2016 Mar 31;11(1 Suppl):391. doi: 10.4081/gh.2016.391.

9.

A breeding site model for regional, dynamical malaria simulations evaluated using in situ temporary ponds observations.

Asare EO, Tompkins AM, Amekudzi LK, Ermert V.

Geospat Health. 2016 Mar 31;11(1 Suppl):390. doi: 10.4081/gh.2016.390.

10.
11.

Assessing the effects of air temperature and rainfall on malaria incidence: an epidemiological study across Rwanda and Uganda.

Colón-González FJ, Tompkins AM, Biondi R, Bizimana JP, Namanya DB.

Geospat Health. 2016 Mar 31;11(1 Suppl):379. doi: 10.4081/gh.2016.379.

12.

A Regional Model for Malaria Vector Developmental Habitats Evaluated Using Explicit, Pond-Resolving Surface Hydrology Simulations.

Asare EO, Tompkins AM, Bomblies A.

PLoS One. 2016 Mar 22;11(3):e0150626. doi: 10.1371/journal.pone.0150626. eCollection 2016.

13.

Waterbirth at Mountain Midwifery Center.

Tompkins A.

Midwifery Today Int Midwife. 2015 Autumn;(115):28-9. No abstract available.

PMID:
26591414
14.

A Generalized Deforestation and Land-Use Change Scenario Generator for Use in Climate Modelling Studies.

Tompkins AM, Caporaso L, Biondi R, Bell JP.

PLoS One. 2015 Sep 22;10(9):e0136154. doi: 10.1371/journal.pone.0136154. eCollection 2015.

15.

Collaboration Is KEY.

Tompkins A.

Midwifery Today Int Midwife. 2015 Spring;(113):55-6. No abstract available.

PMID:
26309938
16.

The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy.

Tompkins AJ, Chatterjee D, Maddox M, Wang J, Arciero E, Camussi G, Quesenberry PJ, Renzulli JF.

J Extracell Vesicles. 2015 Jun 30;4:23815. doi: 10.3402/jev.v4.23815. eCollection 2015.

17.

Unilateral ear and temporomandibular joint discomfort.

Lanigan A, Tompkins AJ, Rivera A.

JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):873-4. doi: 10.1001/jamaoto.2014.1472. No abstract available.

PMID:
25123358
18.

Cavernosal Abscess due to Streptococcus Anginosus: A Case Report and Comprehensive Review of the Literature.

Dugdale CM, Tompkins AJ, Reece RM, Gardner AF.

Curr Urol. 2013 Aug;7(1):51-6. doi: 10.1159/000343555. Epub 2013 Jul 28.

19.

A midwife between worlds.

Tompkins A.

Midwifery Today Int Midwife. 2014 Spring;(109):55-6. No abstract available.

PMID:
24734501
20.

Surprise...it's a placenta!

Tompkins A.

Midwifery Today Int Midwife. 2014 Spring;(109):45. No abstract available.

PMID:
24734494
21.

Decreasing suprapubic tube-related injuries: results of case series and comprehensive literature review.

Tompkins AJ, Travis M, Watne RE, Lasser M, Ellsworth P.

Urol Nurs. 2014 Jan-Feb;34(1):9-17. Review.

PMID:
24716375
22.

Impact of climate change on global malaria distribution.

Caminade C, Kovats S, Rocklov J, Tompkins AM, Morse AP, Colón-González FJ, Stenlund H, Martens P, Lloyd SJ.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3286-91. doi: 10.1073/pnas.1302089111. Epub 2014 Feb 3.

23.

Multisectoral climate impact hotspots in a warming world.

Piontek F, Müller C, Pugh TA, Clark DB, Deryng D, Elliott J, Colón González Fde J, Flörke M, Folberth C, Franssen W, Frieler K, Friend AD, Gosling SN, Hemming D, Khabarov N, Kim H, Lomas MR, Masaki Y, Mengel M, Morse A, Neumann K, Nishina K, Ostberg S, Pavlick R, Ruane AC, Schewe J, Schmid E, Stacke T, Tang Q, Tessler ZD, Tompkins AM, Warszawski L, Wisser D, Schellnhuber HJ.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3233-8. doi: 10.1073/pnas.1222471110. Epub 2013 Dec 16.

24.

"There's no chasing involved": cis/trans relationships, "tranny chasers," and the future of a sex-positive trans politics.

Tompkins AB.

J Homosex. 2014;61(5):766-80. doi: 10.1080/00918369.2014.870448.

PMID:
24294827
25.

Relative importance of climatic, geographic and socio-economic determinants of malaria in Malawi.

Lowe R, Chirombo J, Tompkins AM.

Malar J. 2013 Nov 14;12:416. doi: 10.1186/1475-2875-12-416.

26.
27.

Alcohol-related emergency department attendances: is preloading a risk factor? Cross-sectional survey.

Boyle A, Wee N, Harris R, Tompkins A, Soper M, Porter C.

Int J Emerg Med. 2010 Jul 13;3(3):151-5. doi: 10.1007/s12245-010-0184-x.

28.

The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore.

Brookes PS, Morse K, Ray D, Tompkins A, Young SM, Hilchey S, Salim S, Konopleva M, Andreeff M, Phipps R, Bernstein SH.

Cancer Res. 2007 Feb 15;67(4):1793-802.

30.

Direct evidence for S-nitrosation of mitochondrial complex I.

Burwell LS, Nadtochiy SM, Tompkins AJ, Young S, Brookes PS.

Biochem J. 2006 Mar 15;394(Pt 3):627-34.

31.

Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition.

Tompkins AJ, Burwell LS, Digerness SB, Zaragoza C, Holman WL, Brookes PS.

Biochim Biophys Acta. 2006 Feb;1762(2):223-31. Epub 2005 Oct 21.

32.

Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer.

Brown KM, Tompkins AJ, Yong S, Aranha GV, Shoup M.

Arch Surg. 2005 Jun;140(6):529-32; discussion 532-3.

PMID:
15967899
33.

Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells.

Itoh S, Lemay S, Osawa M, Che W, Duan Y, Tompkins A, Brookes PS, Sheu SS, Abe J.

J Biol Chem. 2005 Jul 15;280(28):26383-96. Epub 2005 Apr 26.

34.

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

Figg WD, Dahut W, Duray P, Hamilton M, Tompkins A, Steinberg SM, Jones E, Premkumar A, Linehan WM, Floeter MK, Chen CC, Dixon S, Kohler DR, Krüger EA, Gubish E, Pluda JM, Reed E.

Clin Cancer Res. 2001 Jul;7(7):1888-93.

35.

A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.

Kohn EC, Reed E, Sarosy GA, Minasian L, Bauer KS, Bostick-Bruton F, Kulpa V, Fuse E, Tompkins A, Noone M, Goldspiel B, Pluda J, Figg WD, Liotta LA.

Clin Cancer Res. 2001 Jun;7(6):1600-9.

36.

Phenylacetate pharmacokinetics based on iterative two-stage population analysis.

Burstein AH, Reed E, Tompkins AC, Venzon D, Figg WD.

Pharmacotherapy. 2001 Mar;21(3):281-6.

PMID:
11253852
37.

A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer.

Bergan RC, Reed E, Myers CE, Headlee D, Brawley O, Cho HK, Figg WD, Tompkins A, Linehan WM, Kohler D, Steinberg SM, Blagosklonny MV.

Clin Cancer Res. 1999 Sep;5(9):2366-73.

38.

Pharmacokinetics of thalidomide in an elderly prostate cancer population.

Figg WD, Raje S, Bauer KS, Tompkins A, Venzon D, Bergan R, Chen A, Hamilton M, Pluda J, Reed E.

J Pharm Sci. 1999 Jan;88(1):121-5.

PMID:
9874712
39.

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

Senderowicz AM, Headlee D, Stinson SF, Lush RM, Kalil N, Villalba L, Hill K, Steinberg SM, Figg WD, Tompkins A, Arbuck SG, Sausville EA.

J Clin Oncol. 1998 Sep;16(9):2986-99.

PMID:
9738567
40.

A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer.

Thibault A, Figg WD, Bergan RC, Lush RM, Myers CE, Tompkins A, Reed E, Samid D.

Tumori. 1998 Jan-Feb;84(1):87-9.

PMID:
9619724
41.

Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancer.

Feuer JA, Lush RM, Venzon D, Duray P, Tompkins A, Sartor O, Figg WD.

J Investig Med. 1998 Feb;46(2):66-72.

PMID:
9549229
42.
43.

Similar clinical outcomes in African-American and non-African-American males treated with suramin for metastatic prostate cancer.

Bergan RC, Walls RG, Figg WD, Dawson NA, Headlee D, Tompkins A, Steinberg SM, Reed E.

J Natl Med Assoc. 1997 Sep;89(9):622-8.

44.

Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.

Dawson NA, Figg WD, Cooper MR, Sartor O, Bergan RC, Senderowicz AM, Steinberg SM, Tompkins A, Weinberger B, Sausville EA, Reed E, Myers CE.

J Clin Oncol. 1997 Apr;15(4):1470-7.

PMID:
9193342
45.

Suramin-induced neutropenia.

Dawson NA, Lush RM, Steinberg SM, Tompkins AC, Headlee DJ, Figg WD.

Eur J Cancer. 1996 Aug;32A(9):1534-9.

PMID:
8911114
46.

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE.

Clin Cancer Res. 1996 Mar;2(3):483-91.

47.

Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancer.

Figg WD, Dawson N, Middleman MN, Brawley O, Lush RM, Senderowicz A, Steinberg SH, Tompkins A, Reed E, Sartor O.

Acta Oncol. 1996;35(6):763-5. No abstract available.

PMID:
8938230
48.

Phase I study of phenylacetate administered twice daily to patients with cancer.

Thibault A, Samid D, Cooper MR, Figg WD, Tompkins AC, Patronas N, Headlee DJ, Kohler DR, Venzon DJ, Myers CE.

Cancer. 1995 Jun 15;75(12):2932-8.

PMID:
7773944
49.

Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine.

Piscitelli SC, Thibault A, Figg WD, Tompkins A, Headlee D, Lieberman R, Samid D, Myers CE.

J Clin Pharmacol. 1995 Apr;35(4):368-73.

PMID:
7650225
50.

Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study.

Foss FM, Borkowski TA, Gilliom M, Stetler-Stevenson M, Jaffe ES, Figg WD, Tompkins A, Bastian A, Nylen P, Woodworth T, et al.

Blood. 1994 Sep 15;84(6):1765-74.

Supplemental Content

Loading ...
Support Center